The economic burden of obesity in Italy: a cost-of-illness study

Margherita d'Errico, Milena Pavlova, Federico Spandonaro, Margherita d'Errico, Milena Pavlova, Federico Spandonaro

Abstract

Background: Obesity is a complex health disorder that significantly increases the risk of several chronic diseases, and it has been associated with a 5-20-year decrease in life expectancy. The prevalence of obesity is increasing steadily worldwide and Italy follows this trend with an increase of almost 30% in the adult obese population in the last 3 decades. Previous studies estimated that 2-4% of the total health expenditure in Europe is attributed to obesity and it is projected to double by 2050. Currently, there is a lack of sufficient knowledge on the burden of obesity in Italy and most relevant estimates are derived from international studies. The aim of this study is to estimate the direct and indirect costs of obesity in Italy, taking 2020 as the reference year.

Methods: Based on data collected from the literature, a quantitative cost-of-illness (COI) study was performed from a societal perspective focussing on the adult obese population (Body Mass Index (BMI) ≥ 30 kg/m2) in Italy.

Results: The study indicated that the total costs attributable to obesity in Italy amounted to €13.34 billion in 2020 (95% credible interval: €8.99 billion < µ < €17.80 billion). Direct costs were €7.89 billion, with cardiovascular diseases (CVDs) having the highest impact on costs (€6.66 billion), followed by diabetes (€0.65 billion), cancer (€0.33 billion), and bariatric surgery (€0.24 billion). Indirect costs amounted to €5.45 billion, with almost equal contribution of absenteeism (€2.62 billion) and presenteeism (€2.83 billion).

Conclusions: Obesity is associated with high direct and indirect costs, and cost-effective prevention programmes are deemed fundamental to contain this public health threat in Italy.

Keywords: Cancer; Cardiovascular diseases (CVD); Cost analysis; Cost-of-illness (COI); Diabetes; Obesity.

Conflict of interest statement

The authors have no relevant financial or non-financial interests to disclose.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Deterministic (one-way) sensitivity analysis and tornado diagram. Seven variables were tested to address uncertainty of the following parameter values when estimating the economic burden of obesity: (1) obesity prevalence, (2) total costs of bariatric surgery, (3) total costs of obesity-attributable CVDs, (4) total costs of obesity-attributable diabetes, (5) total costs of obesity-attributable cancer, (6) total costs of obesity-associated productivity losses, and (7) rate of eligible patients receiving bariatric surgery. Parameter values are changed through upper and lower bounds to estimate minimum and maximum total obesity costs
Fig. 2
Fig. 2
Probabilistic sensitivity analysis (PSA) performed to address uncertainty of parameter values when estimating the total burden of obesity. The PSA was performed adopting the Monte Carlo method (second order) and calculation of the total obesity costs was replicated with 1,000 simulations

References

    1. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–846. doi: 10.1038/nature05482.
    1. Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ. Res. 2016;118(11):1752–1770. doi: 10.1161/circresaha.115.306883.
    1. Smith SC., Jr Multiple risk factors for cardiovascular disease and diabetes mellitus. Am. J. Med. 2007;120(3 Suppl 1):S3–S11. doi: 10.1016/j.amjmed.2007.01.002.
    1. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry. 2010;67(3):220–229. doi: 10.1001/archgenpsychiatry.2010.2.
    1. Jantaratnotai N, Mosikanon K, Lee Y, McIntyre RS. The interface of depression and obesity. Obes. Res. Clin. Pract. 2017;11(1):1–10. doi: 10.1016/j.orcp.2016.07.003.
    1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England) 2014;384(9945):766–781. doi: 10.1016/s0140-6736(14)60460-8.
    1. Obesity and overweight. (2020). Accessed 14 May 2020
    1. Meldrum DR, Morris MA, Gambone JC. Obesity pandemic: causes, consequences, and solutions-but do we have the will? Fertil. Steril. 2017;107(4):833–839. doi: 10.1016/j.fertnstert.2017.02.104.
    1. The heavy burden of obesity: the economics of prevention. In: Publishing, O. (ed.) PECD Health Policy Studies. OECD, Paris (2019)
    1. Pineda E, Sanchez-Romero LM, Brown M, Jaccard A, Jewell J, Galea G, et al. Forecasting future trends in obesity across Europe: the value of improving surveillance. Obes. Facts. 2018;11(5):360–371. doi: 10.1159/000492115.
    1. Dee A, Kearns K, O'Neill C, Sharp L, Staines A, O'Dwyer V, et al. The direct and indirect costs of both overweight and obesity: a systematic review. BMC Res. Notes. 2014;7:242. doi: 10.1186/1756-0500-7-242.
    1. Obesity and the Economics of Prevention: Fit not Fat—Italy Key Facts. (2020). Accessed 6 July 2020
    1. Atella, V., Kopinska, J.: I costi dell’obesità in Italia. In: Fondazione economia “Tor Vergata” (2012)
    1. d’Angela, D., Giordani, C., Polistena, B., Spandonaro, F.: Dati Economici. In: Obesity Barometer Monitor, pp. 79–86 (2019)
    1. JA-JANPA—Azione comune su nutrizione e attività fisica per la prevenzione dell’obesità infantile. (2015). Accessed 28 June 2020
    1. Foschi, D., Moroni, R., De Luca, M., Navarra, S., Sarro, G., Foletto, M., et al.: Linee guida di chirurgia dell’obesità. In: Società Italiana di Chirurgia dell’Obesità e delle malattie metaboliche (SICOB) (2016)
    1. 1° Italian Obesity Barometer Report. In: Italian Barometer Diabetes Observatory (IBDO) Foundation (2019)
    1. Panico S, Palmieri L, Donfrancesco C, Vanuzzo D, Chiodini P, Cesana G, et al. Preventive potential of body mass reduction to lower cardiovascular risk: the Italian Progetto CUORE study. Prev. Med. 2008;47(1):53–60. doi: 10.1016/j.ypmed.2008.01.023.
    1. Pellai A, Nobile M, Luti C. A quali-quantitative analysis of food advertising in Italian Children's National TV Programming: implications for school based nutrition educational programs. J. Nutr. Therap. 2012;1:82–85.
    1. Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obesity Rev. 2017;18(7):715–723. doi: 10.1111/obr.12551.
    1. Upadhyay J, Farr O, Perakakis N, Ghaly W, Mantzoros C. Obesity as a disease. Med. Clin. North Am. 2018;102(1):13–33. doi: 10.1016/j.mcna.2017.08.004.
    1. Caterson ID, Alfadda AA, Auerbach P, Coutinho W, Cuevas A, Dicker D, et al. Gaps to bridge: misalignment between perception, reality and actions in obesity. Diabetes Obes. Metab. 2019;21(8):1914–1924. doi: 10.1111/dom.13752.
    1. Byford S, Torgerson DJ, Raftery J. Economic note: cost of illness studies. BMJ (Clin. Res. Ed.) 2000;320(7245):1335–1335. doi: 10.1136/bmj.320.7245.1335.
    1. Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin. Mol. Hepatol. 2014;20(4):327–337. doi: 10.3350/cmh.2014.20.4.327.
    1. Tarricone R. Cost-of-illness analysis. What room in health economics? Health Policy. 2006;77(1):51–63. doi: 10.1016/j.healthpol.2005.07.016.
    1. Costa N, Derumeaux H, Rapp T, Garnault V, Ferlicoq L, Gillette S, et al. Methodological considerations in cost of illness studies on Alzheimer disease. Heal. Econ. Rev. 2012;2(1):18. doi: 10.1186/2191-1991-2-18.
    1. Frood S, Johnston LM, Matteson CL, Finegood DT. Obesity, complexity, and the role of the health system. Curr. Obes. Rep. 2013;2(4):320–326. doi: 10.1007/s13679-013-0072-9.
    1. Tremmel M, Gerdtham UG, Nilsson PM, Saha S. Economic burden of obesity: a systematic literature review. Int. J. Environ. Res. Public Health. 2017;14(4):435. doi: 10.3390/ijerph14040435.
    1. Atella V, Kopinska J, Medea G, Belotti F, Tosti V, Mortari AP, et al. Excess body weight increases the burden of age-associated chronic diseases and their associated health care expenditures. Aging. 2015;7(10):882–892. doi: 10.18632/aging.100833.
    1. Lette M, Bemelmans WJ, Breda J, Slobbe LC, Dias J, Boshuizen HC. Health care costs attributable to overweight calculated in a standardized way for three European countries. Eur. J. Health Econ. 2016;17(1):61–69. doi: 10.1007/s10198-014-0655-8.
    1. Fattori di rischio per la salute: fumo, obesità, alcol e sedentarietà. In: Italian Institute for Statistics (2016)
    1. Gold M, Siegel J, Russel L, Weinstein M. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
    1. Bloom BS, Bruno DJ, Maman DY, Jayadevappa R. Usefulness of US cost-of-illness studies in healthcare decision making. Pharmacoeconomics. 2001;19(2):207–213. doi: 10.2165/00019053-200119020-00007.
    1. Hodgson TA. The state of the art of cost-of-illness estimates. Adv. Health Econ. Health Serv. Res. 1983;4:129–164.
    1. Poole C. A history of the population attributable fraction and related measures. Ann. Epidemiol. 2015;25(3):147–154. doi: 10.1016/j.annepidem.2014.11.015.
    1. Muller D, Stock S, Dintsios CM, Chernyak N, Gerber-Grote A, Gloede TD, et al. Checklist for the development and assessment of cost-of-illness studies. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2018;80:744–753. doi: 10.1055/s-0042-124664.
    1. Body Mass Index (BMI). . Accessed 19 May 2020
    1. Nicolucci, A., Sbraccia, P., Guerra, R., Sclaera, G., Pisanti, P., Lauro, R. et al.: Il burden of disease dell’obesità in Italia. In: Health Policy in Non-communicable disease. IBDO Foundation (2015)
    1. Di Zio, M., Fursova, N., Geselma, T., Gießing, S., Guarnera, U., Petrauskiene, J. et al.: Methodology for data validation 1.0. In: Essnet Validat Foundation (2016)
    1. Rowland ML. Self-reported weight and height. Am. J. Clin. Nutr. 1990;52(6):1125–1133. doi: 10.1093/ajcn/52.6.1125.
    1. Spencer EA, Appleby PN, Davey GK, Key TJ. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr. 2002;5(4):561–565. doi: 10.1079/phn2001322.
    1. Niedhammer I, Bugel I, Bonenfant S, Goldberg M, Leclerc A. Validity of self-reported weight and height in the French GAZEL cohort. Int. J. Obes. Relat. Metab. Disorders. 2000;24(9):1111–1118. doi: 10.1038/sj.ijo.0801375.
    1. D’Angela, D., Cambiano, C., Glorioso, V.: PariSanità—Osservatorio per l’equità di accesso alle prestazioni. In: Assobiomedica, C.R.E.A. Sanità (2020)
    1. Giampaoli S, Palmieri L, Donfrancesco C, Lo Noce C, Pilotto L, Vanuzzo D. Cardiovascular health in Italy. Ten-year surveillance of cardiovascular diseases and risk factors: Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey 1998–2012. Eur. J. Prevent. Cardiol. 2015;22(2 Suppl):9–37. doi: 10.1177/2047487315589011.
    1. Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer—viewpoint of the IARC Working Group. N. Engl. J. Med. 2016;375(8):794–798. doi: 10.1056/NEJMsr1606602.
    1. Wilson PWF, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch. Intern. Med. 2002;162(16):1867–1872. doi: 10.1001/archinte.162.16.1867.
    1. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88. doi: 10.1186/1471-2458-9-88.
    1. Andrade C. Understanding relative risk, odds ratio, and related terms: as simple as it can get. J. Clin. Psychiatry. 2015;76(7):e857–861. doi: 10.4088/JCP.15f10150.
    1. Shemilt, I.: CCEMG-EEPI-Centre cost converter, version 1.4. (2014). Accessed 20 July 2020
    1. Gupta S, Richard L, Forsythe A. The humanistic and economic burden associated with increasing body mass index in the EU5. Diabetes Metab Syndrome Obesity. 2015;8:327–338. doi: 10.2147/dmso.s83696.
    1. Borisenko O, Colpan Z, Dillemans B, Funch-Jensen P, Hedenbro J, Ahmed AR. Clinical indications, utilization, and funding of bariatric surgery in Europe. Obes. Surg. 2015;25(8):1408–1416. doi: 10.1007/s11695-014-1537-y.
    1. Desogus D, Menon V, Singhal R, Oyebode O. An Examination of who is eligible and who is receiving bariatric surgery in England: secondary analysis of the health survey for England dataset. Obes. Surg. 2019;29(10):3246–3251. doi: 10.1007/s11695-019-03977-3.
    1. Colao A, Lucchese M, D'Adamo M, Savastano S, Facchiano E, Veronesi C, et al. Healthcare usage and economic impact of non-treated obesity in Italy: findings from a retrospective administrative and clinical database analysis. BMJ Open. 2017;7(2):e013899. doi: 10.1136/bmjopen-2016-013899.
    1. Europan Health Interview Survey. In: European Statistics (EUROSTAT) (2015)
    1. Lehnert T, Sonntag D, Konnopka A, Riedel-Heller S, König HH. Economic costs of overweight and obesity. Best practice & research. Clin. Endocrinol. Metab. 2013;27(2):105–115. doi: 10.1016/j.beem.2013.01.002.
    1. Kolb R, Sutterwala FS, Zhang W. Obesity and cancer: inflammation bridges the two. Curr. Opin. Pharmacol. 2016;29:77–89. doi: 10.1016/j.coph.2016.07.005.
    1. Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metab. Clin. Exp. 2019;92:121–135. doi: 10.1016/j.metabol.2018.11.001.
    1. McDonald ME, Bender DP. Endometrial cancer: obesity, genetics, and targeted agents. Obstet. Gynecol. Clin. North Am. 2019;46(1):89–105. doi: 10.1016/j.ogc.2018.09.006.
    1. Tumminia, A., Vinciguerra, F., Parisi, M., Graziano, M., Sciacca, L., Baratta, R. et al.: Adipose tissue, obesity and adiponectin: role in endocrine cancer risk. Int. J. Mol. Sci. 20(12):2863 (2019). 10.3390/ijms20122863
    1. Atella, V., Piano Mortari, A., Kopinska, J., Belotti, F., Lapi, F., Cricelli, C. et al.: Trends in age-related disease burden and healthcare utilization. Aging Cell 18(1):e12861 (2019). 10.1111/acel.12861
    1. Moretti AM, Tafuri S, Parisi D, Germinario C. Epidemiology of pulmonary embolism in Apulia from analysis of current data. Monaldi Archiv. Chest Dis. 2010;73(1):18–24. doi: 10.4081/monaldi.2010.309.
    1. Overweight and obesity report on data collection for overweight and obesity prevalence and related relative risks. In: International Association for the Study of Obesity (2010)
    1. Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity—results of a meta-analysis. Am. Heart J. 2008;155(2):310–315. doi: 10.1016/j.ahj.2007.10.004.
    1. Worldwide trends in body-mass index Underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet (London, England) 2017;390(10113):2627–2642. doi: 10.1016/s0140-6736(17)32129-3.
    1. I numeri del cancro in Italia. In: AIOM (2014)
    1. Marcellusi A, Viti R, Mecozzi A, Mennini FS. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach. Eur. J. Health Econ. 2016;17(2):139–147. doi: 10.1007/s10198-014-0660-y.
    1. Ringborg A, Nieuwlaat R, Lindgren P, Jönsson B, Fidan D, Maggioni AP, et al. Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace. 2008;10(4):403–411. doi: 10.1093/europace/eun048.
    1. Corrao G, Ghirardi A, Ibrahim B, Merlino L, Maggioni AP. Burden of new hospitalization for heart failure: a population-based investigation from Italy. Eur. J. Heart Fail. 2014;16(7):729–736. doi: 10.1002/ejhf.105.
    1. Scholze J, Alegria E, Ferri C, Langham S, Stevens W, Jeffries D, et al. Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. BMC Public Health. 2010;10(1):529. doi: 10.1186/1471-2458-10-529.
    1. Mantovani LG, Fornari C, Madotto F, Riva MA, Merlino L, Ferrario MM, et al. Burden of acute myocardial infarction. Int. J. Cardiol. 2011;150(1):111–112. doi: 10.1016/j.ijcard.2011.04.030.
    1. Gussoni G, Foglia E, Frasson S, Casartelli L, Campanini M, Bonfanti M, et al. Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients. Thromb. Res. 2013;131(1):17–23. doi: 10.1016/j.thromres.2012.10.008.
    1. Gerzeli S, Tarricone R, Zolo P, Colangelo I, Busca MR, Gandolfo C. The economic burden of stroke in Italy The EcLIPSE Study: economic longitudinal incidence-based project for stroke evaluation. Neurol. Sci. 2005;26(2):72–80. doi: 10.1007/s10072-005-0439-0.
    1. Jönsson B, Hofmarcher T, Lindgren P, Wilking N. The cost and burden of cancer in the European Union 1995–2014. Eur. J. Cancer (Oxford, England: 1990) 2016;66:162–170. doi: 10.1016/j.ejca.2016.06.022.
    1. Peterson MD, Mahmoudi E. Healthcare utilization associated with obesity and physical disabilities. Am. J. Prev. Med. 2015;48(4):426–435. doi: 10.1016/j.amepre.2014.11.007.
    1. Nørtoft E, Chubb B, Borglykke A. Obesity and healthcare resource utilization: comparative results from the UK and the USA. Obes. Sci. Pract. 2017;4(1):41–45. doi: 10.1002/osp4.148.
    1. Drummond M. Cost-of-illness studies: a major headache? Pharmacoeconomics. 1992;2(1):1–4. doi: 10.2165/00019053-199202010-00001.
    1. Konnopka A, Bödemann M, König HH. Health burden and costs of obesity and overweight in Germany. Eur. J. Health Econ. 2011;12(4):345–352. doi: 10.1007/s10198-010-0242-6.
    1. Runkel N, Colombo-Benkmann M, Hüttl TP, Tigges H, Mann O, Sauerland S. Bariatric surgery. Dtsch. Arztebl. Int. 2011;108(20):341–346. doi: 10.3238/arztebl.2011.0341.
    1. Oberlin P, de Peretti C. Bariatric surgery in France from 1997 to 2018. Surg. Obesity Relat. Dis. 2020;16(8):1069–1077. doi: 10.1016/j.soard.2020.04.022.
    1. Goettler A, Grosse A, Sonntag D. Productivity loss due to overweight and obesity: a systematic review of indirect costs. BMJ Open. 2017 doi: 10.1136/bmjopen-2016-014632.
    1. Effertz T, Engel S, Verheyen F, Linder R. The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective. Eur. J. Health Econ. 2016;17(9):1141–1158. doi: 10.1007/s10198-015-0751-4.
    1. Knoll, K., Hauner, H.: A health-economic analysis of the total cost burden caused by obesity and the diseases associated with obesity in the Federal Republic of Germany. Adipositas (2008)
    1. How does Germany compare? Health at a Glance: Europe. In: Organisation for Economic Co-operation and Development (OECD) (2017)
    1. Gesundheitsausgaben in Deutschland in Mio. €. Gliederungsmerkmale: Jahre, Art der Einrichtung, Art der Leistung, Ausgabenträger. . Accessed 1 August 2020
    1. Cartabellotta, N., Cottafava, E., Luceri, R., Mosti, M.: Il definanziamento 2010–2019 del Servizio Sanitario Nazionale. In: Report Osservatorio GIMBE n. 7/2019 (2019)
    1. Klarenbach S, Padwal R, Chuck A, Jacobs P. Population-based analysis of obesity and workforce participation. Obesity (Silver Spring, MD) 2006;14(5):920–927. doi: 10.1038/oby.2006.106.
    1. Ricci JA, Chee E. Lost productive time associated with excess weight in the US workforce. J. Occup. Environ. Med. 2005;47(12):1227–1234. doi: 10.1097/01.jom.0000184871.20901.c3.
    1. Kaplan HC, Brady PW, Dritz MC, Hooper DK, Linam WM, Froehle CM, et al. The influence of context on quality improvement success in health care: a systematic review of the literature. Milbank Q. 2010;88(4):500–559. doi: 10.1111/j.1468-0009.2010.00611.x.
    1. Tomoaia-Cotisel A, Scammon DL, Waitzman NJ, Cronholm PF, Halladay JR, Driscoll DL, et al. Context matters: the experience of 14 research teams in systematically reporting contextual factors important for practice change. Ann. Fam. Med. 2013;11(Suppl 1):S115–S123. doi: 10.1370/afm.1549.
    1. Migliore E, Pagano E, Mirabelli D, Baldi I, Gregori D, Zocchetti C, et al. Hospitalization rates and cost in severe or complicated obesity: an Italian cohort study. BMC Public Health. 2013;13:544. doi: 10.1186/1471-2458-13-544.
    1. Patil H, Astik G, House JA, O'Keefe JH, Main ML. Prevalence of grade II and III obesity among patients hospitalized with cardiovascular diagnoses in 2002 v 2009. Missouri Med. 2012;109(5):397–401.
    1. Body Mass Index (BMI). (2016). Accessed 15 May 2020
    1. Indagine multiscopo: “Aspetti della vita quotidiana”. In: Istituto nazionale di statistica (ISTAT) (2018)
    1. Indagine “Sorveglianza Passi”. In: EpiCentro (2018)

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe